DC Chemicals

All products / DC23179

EGF816 mesylate
CAT. NO. DC23179

EGF816 mesylate

Pack sizes and prices

Pack sizePrice
100 mg$600 USDRequest a quote →
250 mg$1,200 USDRequest a quote →
1 g$2,400 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively; shows potent inhibition of pEGFR levels in H3255, HCC827, and H1975 with EC50 of 5, 1, and 3 nM, which harbor the L858R, Ex19del, and L858R/T790M mutations, respectively, inhibitscell proliferation with EC50 of 9, 11, and 25 nM, but not the WT EGFR-containing patient-derived cell lines; potently inhibits the most common EGFR mutations L858R, Ex19del, and T790M in vitro; causes tumor regressions in vivo in several patient-derived xenograft models, also demonstrates antitumor activity in exon 20 insertion mutant model.Lung CancerPhase 3 Clinical

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC23179
Product nameEGF816 mesylate
CAS1508250-72-3
Molecular formulaC27H35ClN6O5S
Molecular weight591.122
Purity>98%
SMILESO=C(C1=CC(C)=NC=C1)NC2=NC3=CC=CC(Cl)=C3N2[C@H]4CN(C(/C=C/CN(C)C)=O)CCCC4.CS(=O)(O)=O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — EGF816 mesylate (DC23179)

Related research products